Bronchiolitis is the most common lower respiratory tract infections in infants. It is time to reach a unique clinical definition, encompassing the acute onset of respiratory distress with cough, tachypnoea, retraction and diffuse crackles on auscultation in infants aged less than 12 months.
Acute bronchiolitis is the most common lower respiratory tract infection in infants less than 12 months of age, and it is the leading cause of hospitalisation in this age group, particularly in infants younger than six months. It is mainly caused by respiratory syncytial virus (RSV) and shows a seasonal pattern, with peak incidence occurring during winter, but other respiratory viruses can often be involved. 1 Particularly, infants with RSV bronchiolitis are younger, have been breastfed for a shorter time and have a more severe form of bronchiolitis with prevalent chest X-ray findings of diffuse air trapping, whereas, human Rhinovirus (hRV), the second most frequent virus involved, seems to cause a milder form of bronchiolitis and affecting infants with a higher eosinophils count and, possibly, with an atopic predisposition. 1 Each year 150 million new cases of bronchiolitis are reported worldwide with an increasing trend in medical visits and total hospitalisations along with the diagnosis of bronchiolitis.
Despite the fact that bronchiolitis is an 'old' disease, several aspects are still debated. First, a clear definition of this entity is still lacking. According to the European definition, bronchiolitis is a clinical diagnosis requiring epidemiological data, such as the epidemic period (December to March), the age of infants and the specific clinical appearance (signs of an upper respiratory infection: runny nose, fever, chough, followed by respiratory distress with diffuse crackles on auscultation). 2 On the contrary, the American Pediatric Academy defines bronchiolitis as the first episode of acute viral wheeze occurring in infants less than two years old. It is evident that this definition likely overlaps the early presentation of wheezing or bronchial hyper-responsiveness. 3 To exclude infants with virus-associated episodes of wheezing, we should consider bronchiolitis only in infants younger than 12 months presenting with their first episode of lower respiratory infection, who had diffuse crackles on auscultation. 4 Wheezing is a high-pitched, musical, adventitious lung sound produced by turbulent airflow through a narrowed airway, whereas crackles are caused by the 'popping open' of small airways and alveoli collapsed by fluid, thus possibly reflecting two different entities affecting two different lung structures. Second, it is a self-limiting disease and it should be managed only with supportive care. Reduced feeding is common and very young infants may present with apnoeic episodes, thus leading to hospitalisation, which is required by 2-3% of infants affected. 5 Some patients, particularly when risk factors are present, can manifest a severe disease and the admission to the intensive care unit may be required. 
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disease. 6 The use of asthma controller medication in children after hospitalisation for bronchiolitis is equally high with increasing health costs. Host and viral factors actively interact during respiratory infections, but it is still debated whether the virus directly modifies the host immune response or it simply identifies infants somehow prone to wheeze.
Recent evidence suggests that the age limit should be further restricted to six months because the clinical entity seems to even differ over this age in terms of aetiology, clinical severity and possibly pathogenesis. 4 It remains to be determined whether the clinical manifestations of bronchiolitis differ in children younger than six months or if it is a separate disease.
In conclusion, we believe that bronchiolitis needs to reach a unique definition, characterised by acute onset of respiratory distress with cough, tachypnoea, retraction and diffuse crackles on auscultation in infants less than 12 months, or even six months of age. ■
